Business Standard

Volume Shocker: Mastek

A combined 386,658 shares have changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks

SI Reporter  |  Mumbai 

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

had reported first quarterly profit of Rs 7.1 crore after six quarters for the quarter ended March 2012 and management commentary suggests likely continuation of this trend.

The operational performance was healthy across major geographies and verticals with the company generating around Rs 32 crore from cash flow from operations.

Analyst at ICICI Direct Research upgraded the stock to BUY with a target price of Rs 120, on positive outlook by the management may minimise the risk of book value erosion. 

RECOMMENDED FOR YOU

Volume Shocker: Mastek

A combined 386,658 shares have changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

Mastek has surged 14% to Rs 105 on back of over fifteen-fold jump in trading volumes in noon deals on the National Stock Exchange. As many as a combined 386,658 shares have already changed hands on the counter in noon trades, against an average sub 25,000 shares that were traded daily in past two weeks on both the exchanges.

had reported first quarterly profit of Rs 7.1 crore after six quarters for the quarter ended March 2012 and management commentary suggests likely continuation of this trend.

The operational performance was healthy across major geographies and verticals with the company generating around Rs 32 crore from cash flow from operations.

Analyst at ICICI Direct Research upgraded the stock to BUY with a target price of Rs 120, on positive outlook by the management may minimise the risk of book value erosion. 

image

LIVE MARKET

BSE

  ( %)

NSE

  ( %)

Widgets Magazine

More News

STOCK WATCH

Company Price() Chg(%)
Take Solutions 154.85 19.99
Vijaya Bank 34.30 15.88
Sequent Scien. 864.25 15.19
Jindal Steel 63.45 10.44
Yamini Invest 46.65 9.64
> More on BSE Gainers
Company Price() Chg(%)
Vijaya Bank 34.25 16.10
Federal-Mogul Go 339.10 12.06
Jindal Steel 63.50 10.63
Suzlon Energy 15.75 9.38
Lupin 1802.85 9.08
> More on NSE Gainers
Company Price() Chg(%)
SE Investments 181.10 -7.01
Alembic Pharma 596.55 -5.77
Crompton Greaves 126.90 -5.33
ISGEC Heavy 4484.50 -5.12
Bosch 16133.20 -4.97
> More on BSE Gainers
Company Price() Chg(%)
Alembic Pharma 593.20 -6.33
Bosch 16089.10 -5.24
Ess Dee Alumin. 165.15 -4.98
Zydus Wellness 700.00 -4.68
J B Chem & Pharm 256.95 -4.46
> More on NSE Gainers
Widgets Magazine
Widgets Magazine
Widgets Magazine

Derivatives

Index
Instrument Type
Expiry Date
Option Type
Strike Price